Role of tumor-associated macrophages in renal cell carcinoma

Shinichi Ikemoto1, Naomasa Yoshida, Keisuke Narita

  • 1Department of Urology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.

Oncology Reports
|October 10, 2003
PubMed

Insights

Tumor-associated macrophages (TAM) in renal cell carcinoma (RCC) spontaneously produce inflammatory cytokines. These TAM significantly enhance cancer cell proliferation, suggesting a key role in RCC progression.

Area of Science:

  • Oncology
  • Immunology
  • Cell Biology

Background:

  • Renal cell carcinoma (RCC) is a significant health concern.
  • The role of tumor-associated macrophages (TAM) in RCC pathogenesis is not fully understood.
  • Understanding TAM function is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the biological significance of TAM in renal cell carcinoma (RCC).
  • To compare the cytokine production of TAM with peripheral blood monocytes.
  • To assess the impact of TAM on RCC cell proliferation.

Main Methods:

  • Isolation of TAM from surgically removed RCC tissues and monocytes from peripheral blood.
  • Comparison of cytokine production (IL-6, TNFα, IL-1β) with and without lipopolysaccharide (LPS) stimulation.
  • Co-culture of TAM with RCC cell lines (A498, K562) to evaluate proliferation effects.

Main Results:

  • TAM spontaneously produced IL-6, TNFα, and IL-1β, unlike monocytes.
  • Monocytes produced higher levels of these cytokines than TAM upon LPS stimulation.
  • A positive correlation was observed between TAM TNFα production and tumor size in stage T1 RCC.
  • TAM significantly enhanced RCC cell proliferation in vitro.

Conclusions:

  • TAM exhibit distinct cytokine production profiles compared to monocytes in RCC patients.
  • TAM-derived TNFα correlates with tumor progression in early-stage RCC.
  • TAM play a crucial role in promoting RCC cell proliferation, indicating their importance in tumor progression.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...